Twitter | Search | |
Edward Ovalles
A fan of tech/science. A Husband, Father, Family, Friends and Love is what's important to me.
3,163
Tweets
318
Following
179
Followers
Tweets
Edward Ovalles retweeted
Engadget 18h
The world's first hydrogen train is now in service
Reply Retweet Like
Edward Ovalles Sep 17
knock knock! Anybody home?
Reply Retweet Like
Edward Ovalles Sep 14
Reply Retweet Like
Edward Ovalles Sep 13
Significant in the sense that with you can have tighter control of your glucose and much much less hypoglycemia events. Alas Glucose Homeostatis. CGMs keeps and honest and aspart's nose is growing.
Reply Retweet Like
Edward Ovalles retweeted
Luigi Piccioli Sep 12
Afrezza is a rapid acting, inhaled mealtime for Type 1 and Type 2 . How is different from other fast-acting insulin?
Reply Retweet Like
Edward Ovalles Sep 9
Reply Retweet Like
Edward Ovalles Sep 7
Replying to @RooksLeAnne
Reply Retweet Like
Edward Ovalles Sep 6
Replying to @ananavarro
Reply Retweet Like
Edward Ovalles Sep 5
Finally a BP took notice of TS+device & the potential that is has. Over 800 patents. SO and Adam are blinded by the fact that Technosphere will be *the* premier delivery system to the lungs. With 40 different proven APIs, AF and SO tried to steer investors to focus on Afrezza.
Reply Retweet Like
Edward Ovalles Sep 4
Replying to @BSharp6669
😂😂😂
Reply Retweet Like
Edward Ovalles retweeted
NosVino Sep 1
Looking for a sexy alternative for Sauvignon Blanc? Why not venture out of your comfort zone and try a Gruner Veltliner. If you like medium Body Reds like Chianti or Cabernet Franc you should definitely try a Tempranillo from Spain. Wine tasting 2-5pm today!
Reply Retweet Like
Edward Ovalles retweeted
AFREZZA® Aug 31
Did you know that high A1c numbers have been shown to correspond to the risk of diabetes complications (heart, eye, kidney + nerve)? See Safety:
Reply Retweet Like
Edward Ovalles retweeted
LeAnne Rooks Aug 29
MannKind AFREZZA Commercial: Unexpected Moments via
Reply Retweet Like
Edward Ovalles Aug 29
Aspart's hypoglycemic incident rate is as bad as their PK/PD.
Reply Retweet Like
Edward Ovalles Aug 29
Again "one monomer at a time". We already blew Sanofi out of the water on sales. It is embarrassing how MNKD managed to surpass their sales number with 1/3 of the sales force of Sanofi's. Everything in between Sanofi's impotent sales force and now is all noise. Enjoy the pics
Reply Retweet Like
Edward Ovalles Aug 29
Replying to @realDonaldTrump
We've been doing great since 2012
Reply Retweet Like
Edward Ovalles Aug 29
Ohh no is risingskeleton. First you bash on the effectiveness of afrezza and now you are bashing the stock price. You have been singing the same tune for 3+ years and no cigar. Say hi to your husband SO. Remember we will get there - "one monomer at a time".
Reply Retweet Like
Edward Ovalles Aug 29
A stubborn doctor is not a person that should be in the field. If a diabetes cure were to come out what would happen to all the endos?
Reply Retweet Like
Edward Ovalles Aug 28
Maybe b/c there is nothing like it and there only argument is inhalation causes lungs issues or maybe they think its Exubera. For an endo who went to school for 12 yrs, & not do their DD on a drug, must be embarrassing that they never heard of . Patients will decide.
Reply Retweet Like
Edward Ovalles Aug 28
Stay tuned. The healthcare system will be changing in the next decade and thank God for social media. I agree that Mannkind has not done a gr8t job on getting the word out but disagree with endos avoiding like a plague. I wonder y they think its like a plague? Facts pls.
Reply Retweet Like